Skip to main
VTR
VTR logo

Ventas (VTR) Stock Forecast & Price Target

Ventas (VTR) Analyst Ratings

Based on 14 analyst ratings
Buy
Strong Buy 14%
Buy 64%
Hold 21%
Sell 0%
Strong Sell 0%

Bulls say

Ventas operates with a diversified healthcare portfolio comprising nearly 1,400 in-place properties across various sectors, including senior housing, medical offices, and life sciences, which positions the company favorably in the healthcare real estate investment trust (REIT) space. The firm's strategic approach includes seeking investment opportunities in mature healthcare systems similar to that of the United States, thereby enhancing its geographic diversification with properties in Canada and the United Kingdom. Additionally, Ventas's management is actively monitoring and reducing exposure in concentrated markets like California, Texas, Florida, and New York, which helps mitigate potential risks associated with reimbursement rate changes and other tenant-specific issues, contributing to a positive long-term outlook for the company.

Bears say

Ventas faces a negative outlook primarily due to potential reductions in Medicare and Medicaid reimbursements, which could adversely affect its rent coverage ratios and result in rent restructuring. The company also contends with tenant concentration risk, as revenue exposure to individual tenants exceeds 5%, making it vulnerable to adverse changes in reimbursement rates. Additionally, in a rising interest rate environment, the healthcare REIT sector, characterized by bond-like cash flows, is expected to underperform, further complicating Ventas's access to critical capital markets for growth.

Ventas (VTR) has been analyzed by 14 analysts, with a consensus rating of Buy. 14% of analysts recommend a Strong Buy, 64% recommend Buy, 21% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Ventas and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Ventas (VTR) Forecast

Analysts have given Ventas (VTR) a Buy based on their latest research and market trends.

According to 14 analysts, Ventas (VTR) has a Buy consensus rating as of Nov 26, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $77.93, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $77.93, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Ventas (VTR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.